If the insurance company is like those in the U.S., their denial may be rather automatic for a drug that hasn't been tested and approved for your diagnosis, but you and your doctor may convince them to change their minds by appealing and making the case for Revlimid treatment, although it sounds like you are still exploring other options.
For those who don't know what MDS/MPD-UC means, MDS stands for myelodysplastic syndrome, MPD for myeloproliferative disease, and UC for unclassifiable. It describes a disease with characteristics of both myelodysplastic disease (and its various subclassifications) and myeloproliferative disease that does not fall into particular known categories such as chronic myeloproliferative disorder (CMPD).
|